Cargando...
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
With more than 80% of all diagnosed lung cancer cases, non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Exact diagnosis is mostly very late and advanced-stage NSCLCs are inoperable at admission. Tailored therapies with tyrosine kinase inhibitors are only availa...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5777811/ https://ncbi.nlm.nih.gov/pubmed/29383199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22975 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|